The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
19 | 17 | 59 | 91 |
Growth
|
45 | 97 | 51 | 25 |
Safety
|
10 | 12 | 10 | 4 |
Sentiment
|
98 | 82 | 84 | 90 |
|
28 | 51 | 48 | 56 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
71 | 67 | 68 | 73 |
Opinions Change
|
50 | 50 | 50 | 50 |
Pro Holdings
|
n/a | 49 | 55 | 49 |
Market Pulse
|
100 | 100 | 100 | 100 |
Sentiment
|
98 | 82 | 84 | 90 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
19 | 17 | 59 | 91 |
Growth
|
45 | 97 | 51 | 25 |
|
10 | 12 | 10 | 4 |
Combined
|
10 | 30 | 23 | 36 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
32 | 25 | 44 | 57 |
Price vs. Earnings (P/E)
|
49 | 46 | 75 | 84 |
Price vs. Book (P/B)
|
18 | 10 | 38 | 61 |
Dividend Yield
|
26 | 23 | 72 | 69 |
Value
|
19 | 17 | 59 | 91 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
47 | 87 | 64 | 77 |
Profit Growth
|
46 | 100 | 100 | 18 |
Capital Growth
|
22 | 47 | 15 | 61 |
Stock Returns
|
75 | 100 | 15 | 3 |
Growth
|
45 | 97 | 51 | 25 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
4 | 3 | 2 | 6 |
Refinancing
|
29 | 37 | 43 | 33 |
Liquidity
|
34 | 20 | 8 | 15 |
|
10 | 12 | 10 | 4 |
Discover high‑ranked alternatives to Johnson Health Tech and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.